Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in Adults

NCT02669121 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

4748

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

BIOLOGICAL: NoV Placebo-matching Saline
BIOLOGICAL: NoV GI.1/GII.4 Bivalent VLP Vaccine

Sponsor

Takeda